| 000 | 01514 a2200445 4500 | ||
|---|---|---|---|
| 005 | 20250517034925.0 | ||
| 264 | 0 | _c20160315 | |
| 008 | 201603s 0 0 eng d | ||
| 022 | _a1932-6203 | ||
| 024 | 7 |
_a10.1371/journal.pone.0123416 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aKottaridis, Panagiotis D | |
| 245 | 0 | 0 |
_aTwo-Stage Priming of Allogeneic Natural Killer Cells for the Treatment of Patients with Acute Myeloid Leukemia: A Phase I Trial. _h[electronic resource] |
| 260 |
_bPloS one _c2015 |
||
| 300 |
_ae0123416 p. _bdigital |
||
| 500 | _aPublication Type: Clinical Trial, Phase I; Journal Article; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 | _aAdult |
| 650 | 0 | 4 | _aAged |
| 650 | 0 | 4 |
_aCell Transplantation _xadverse effects |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aKiller Cells, Natural _ximmunology |
| 650 | 0 | 4 |
_aLeukemia, Myeloid, Acute _ximmunology |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 | _aMonitoring, Physiologic |
| 650 | 0 | 4 | _aTransplantation Conditioning |
| 650 | 0 | 4 | _aTransplantation, Homologous |
| 650 | 0 | 4 | _aUnited Kingdom |
| 650 | 0 | 4 | _aYoung Adult |
| 700 | 1 | _aNorth, Janet | |
| 700 | 1 | _aTsirogianni, Maria | |
| 700 | 1 | _aMarden, Chloe | |
| 700 | 1 | _aSamuel, Edward R | |
| 700 | 1 | _aJide-Banwo, Sam | |
| 700 | 1 | _aGrace, Sarah | |
| 700 | 1 | _aLowdell, Mark W | |
| 773 | 0 |
_tPloS one _gvol. 10 _gno. 6 _gp. e0123416 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1371/journal.pone.0123416 _zAvailable from publisher's website |
| 999 |
_c24970022 _d24970022 |
||